BMEYE

**BMEYE** is a Netherlands-based non-invasive cardiovascular monitoring company that has been pioneering advanced finger arterial pressure and cardiac output technologies for global healthcare since **2005**. The company's product offerings include **Finapres**, **Portapres**, **Finometer**, **BeatScope**, **Modelflow**, **Space instrumentation**, **Cardiopres**, **Oxyflow**, **Nexfin**, and **ccNexfin**, catering to various fields such as cardiology, anesthesiology, sleep observation, physiology, neurology, and internal medicine; and emergency, acute, intensive, and intermediate care. Additionally, it has received a notable **€6.00M Series B investment** from **360 Capital, Earlybird, LSP BioVentures, TechFund** on **08 October 2009**. With a focus on the research and development of medical technologies for cardiovascular monitoring, BMEYE has positioned itself as a promising player in the **Biotechnology, Health Care, and Medical Devices** industries. The company's headquarters is located in **Amsterdam, the Netherlands**. BMEYE's dedication to innovation in non-invasive monitoring technologies, backed by significant investment, positions it as a noteworthy venture in the healthcare sector.